Patrick S. Chang
Roche (United States) · 14 works · 171 citations · h-index 4
Top works
- Anti-TIGIT antibody improves PD-L1 blockade through myeloid and Treg cells
- SPEX: A modular end-to-end platform for high-plex tissue spatial omics analysis
- Obligate role for Rock1 and Rock2 in adult stem cell viability and function
- Author Correction: Anti-TIGIT antibody improves PD-L1 blockade through myeloid and Treg cells
- Abstract PR002: T cell engager therapy affects the spatial distribution and phenotype of T cells in the tumor microenvironment
- Anti-TIGIT antibody tiragolumab improves PD-L1 blockade via myeloid and Treg cells
- P021 Obinutuzumab induces histological remission and deep kidney parenchymal B-cell depletion in patients with lupus nephritis: exploratory analyses from the REGENCY trial
- WCN26-3469 OBINUTUZUMAB INDUCES HISTOLOGIC REMISSION AND DEEP KIDNEY PARENCHYMAL B-CELL DEPLETION IN PATIENTS WITH LUPUS NEPHRITIS: EXPLORATORY ANALYSES FROM THE REGENCY TRIAL
- Publisher Correction: Anti-TIGIT antibody improves PD-L1 blockade through myeloid and Treg cells
- PT2:06 Obinutuzumab induces histological remission and deep kidney parenchymal B-cell depletion in patients with lupus nephritis: exploratory analyses of the phase III regency trial
- An Automated, Ventana Discovery Platform-based Imaging Workflow for Simultaneous Quantification of B Cells, Plasma Cells, and Plasmablasts in FFPE Human Tissues
- Obinutuzumab Induces Histological Remission and Deep Kidney Parenchymal B-Cell Depletion in Patients with Lupus Nephritis: Exploratory Analyses of the Phase III REGENCY Trial
- Resolving the renal microenvironment: a 5-plex immunofluorescence workflow to quantify B-lineage cells in FFPE lupus nephritis biopsies
- Publisher Correction: Anti-TIGIT antibody improves PD-L1 blockade through myeloid and Treg cells